BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 35715305)

  • 1. The association of vagina equivalent dose in 2Gy fraction (EQD
    Ruanla J; Muangwong P; Kittidachanan K; Tippanya D; Thongsuk W; Kongsa A; Galalae RM; Tharavichitkul E
    Brachytherapy; 2022; 21(5):658-667. PubMed ID: 35715305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaginal Dose Is Associated With Toxicity in Image Guided Tandem Ring or Ovoid-Based Brachytherapy.
    Susko M; Craciunescu O; Meltsner S; Yang Y; Steffey B; Cai J; Chino J
    Int J Radiat Oncol Biol Phys; 2016 Apr; 94(5):1099-105. PubMed ID: 26883564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaginal 11-point and volumetric dose related to late vaginal complications in patients with cervical cancer treated with external beam radiotherapy and image-guided adaptive brachytherapy.
    Dankulchai P; Harn-Utairasmee P; Prasartseree T; Nakkasae P; Trikhirhisthit K; Sittiwong W; Thephamongkhol K; Petsuksiri J; Apiwarodom N; Iampongpaiboon P; Chansilpa Y
    Radiother Oncol; 2022 Sep; 174():77-86. PubMed ID: 35839936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose rate in the highest irradiation area of the rectum correlates with late rectal complications in patients treated with high-dose-rate computed tomography-based image-guided brachytherapy for cervical cancer.
    Isohashi F; Akino Y; Matsumoto Y; Suzuki O; Seo Y; Tamari K; Sumida I; Sawada K; Ueda Y; Kobayashi E; Tomimatsu T; Nakanishi E; Nishi T; Kimura T; Ogawa K
    J Radiat Res; 2021 May; 62(3):494-501. PubMed ID: 33866361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dose-effect relationship between vaginal dose points and vaginal stenosis in cervical cancer: An EMBRACE-I sub-study.
    Westerveld H; Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Spampinato S; Sturdza A; Nesvacil N; Bruheim K; Hellebust TP; Pieters BR; Kirisits C; Jürgenliemk-Schulz IM; Pötter R; de Leeuw AAC
    Radiother Oncol; 2022 Mar; 168():8-15. PubMed ID: 35063582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaginal dose de-escalation in image guided adaptive brachytherapy for locally advanced cervical cancer.
    Mohamed S; Lindegaard JC; de Leeuw AA; Jürgenliemk-Schulz I; Kirchheiner K; Kirisits C; Pötter R; Tanderup K
    Radiother Oncol; 2016 Sep; 120(3):480-485. PubMed ID: 27267048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose at posterior-inferior border of symphysis point: A predictor for vaginal stricture in cervical cancer.
    Singh A; Mani N; Aggarwal LM; Agarwal S; Mourya A; Verma A; Bagchi A; Gupta N; Choudhary S
    Brachytherapy; 2023; 22(5):616-622. PubMed ID: 37286402
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicentre evaluation of a novel vaginal dose reporting method in 153 cervical cancer patients.
    Westerveld H; de Leeuw A; Kirchheiner K; Dankulchai P; Oosterveld B; Oinam A; Hudej R; Swamidas J; Lindegaard J; Tanderup K; Pötter R; Kirisits C;
    Radiother Oncol; 2016 Sep; 120(3):420-427. PubMed ID: 27237058
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose-effect relationship and risk factors for vaginal stenosis after definitive radio(chemo)therapy with image-guided brachytherapy for locally advanced cervical cancer in the EMBRACE study.
    Kirchheiner K; Nout RA; Lindegaard JC; Haie-Meder C; Mahantshetty U; Segedin B; Jürgenliemk-Schulz IM; Hoskin PJ; Rai B; Dörr W; Kirisits C; Bentzen SM; Pötter R; Tanderup K;
    Radiother Oncol; 2016 Jan; 118(1):160-6. PubMed ID: 26780997
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Definitive radiation for advanced cervix cancer is not associated with vaginal shortening-a prospective vaginal length and dose correlation.
    Owrangi A; Medrano A; Gao Y; Kazemifar S; Hrycushko B; Medin P; Nwachukwu C; Jia X; Albuquerque K
    Brachytherapy; 2024; 23(2):136-140. PubMed ID: 38242726
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaginal dose point reporting in cervical cancer patients treated with combined 2D/3D external beam radiotherapy and 2D/3D brachytherapy.
    Westerveld H; Pötter R; Berger D; Dankulchai P; Dörr W; Sora MC; Pötter-Lang S; Kirisits C
    Radiother Oncol; 2013 Apr; 107(1):99-105. PubMed ID: 23639578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Toxicities and dose-volume histogram parameters of MRI-based brachytherapy for cervical cancer.
    Kim Y; Kim YJ; Kim JY; Lim YK; Jeong C; Jeong J; Kim M; Lim MC; Seo SS; Park SY
    Brachytherapy; 2017; 16(1):116-125. PubMed ID: 27876378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Feasibility of ureter delineation and dose recording in the assessment of ureteric stenosis during brachytherapy for cervical cancer.
    Sarwar A; Lalli N; Aughwane P; Eminowicz G
    Brachytherapy; 2021; 20(4):755-764. PubMed ID: 33926834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of dose to functional sub-structures in the lower urinary tract in locally advanced cervical cancer radiotherapy.
    Spampinato S; Fokdal L; Marinovskij E; Axelsen S; Pedersen EM; Pötter R; Lindegaard JC; Tanderup K
    Phys Med; 2019 Mar; 59():127-132. PubMed ID: 30772142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vaginal dose-surface maps in cervical cancer brachytherapy: Methodology and preliminary results on correlation with morbidity.
    Serban M; de Leeuw AAC; Tanderup K; Jürgenliemk-Schulz IM
    Brachytherapy; 2021; 20(3):565-575. PubMed ID: 33741274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long term experience with 3D image guided brachytherapy and clinical outcome in cervical cancer patients.
    Ribeiro I; Janssen H; De Brabandere M; Nulens A; De Bal D; Vergote I; Van Limbergen E
    Radiother Oncol; 2016 Sep; 120(3):447-454. PubMed ID: 27157510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dose delivered to vagina using two different intracavitary brachytherapy applicators for carcinoma cervix.
    Bajwa HK; Talluri AK; Maqbool A; Reddy D; Singareddy R; Sresty NM; Raju AK
    Brachytherapy; 2022; 21(2):151-157. PubMed ID: 34756698
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility study of toxicity outcomes using GEC-ESTRO contouring guidelines on CT based instead of MRI-based planning in locally advanced cervical cancer patients.
    Koh V; Choo BA; Lee KM; Tan TH; Low JH; Ng SY; Ilancheran A; Shen L; Tang J
    Brachytherapy; 2017; 16(1):126-132. PubMed ID: 27816539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Manifestation pattern of early-late vaginal morbidity after definitive radiation (chemo)therapy and image-guided adaptive brachytherapy for locally advanced cervical cancer: an analysis from the EMBRACE study.
    Kirchheiner K; Nout RA; Tanderup K; Lindegaard JC; Westerveld H; Haie-Meder C; Petrič P; Mahantshetty U; Dörr W; Pötter R
    Int J Radiat Oncol Biol Phys; 2014 May; 89(1):88-95. PubMed ID: 24725693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vaginal packing volume impact on dose parameters during radiography and computed tomography based postoperative brachytherapy of cervical carcinoma.
    Tomasevic A; Plesinac-Karapandzic V; Stojanovic-Rundic S; Vuckovic S; Stevanovic J; Gavrilovic D; Nadrljanski M
    J BUON; 2017; 22(6):1509-1516. PubMed ID: 29332346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.